AIM
SRTA

ARK Investment Management’s Strata Critical Medical Inc SRTA Stock Holding History

ARK Investment Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.2M Buy
7,455,284
+344,624
+5% +$1.66M 0.24% 65
2025
Q4 		$34.2M Buy
7,110,660
+706,075
+11% +$3.42M 0.23% 69
2025
Q3 		$32.4M Sell
6,404,585
-2,195,049
-26% -$9.7M 0.19% 70
2025
Q2 		$34.7M Buy
8,599,634
+458,990
+6% +$1.49M 0.25% 59
2025
Q1 		$22.2M Buy
8,140,644
+89,545
+1% +$321K 0.22% 61
2024
Q4 		$34.2M Buy
8,051,099
+833,848
+12% +$3.17M 0.29% 53
2024
Q3 		$21.2M Buy
7,217,251
+774,114
+12% +$2.46M 0.19% 64
2024
Q2 		$22.4M Buy
6,443,137
+230,216
+4% +$768K 0.2% 65
2024
Q1 		$17.7M Sell
6,212,921
-280,864
-4% -$867K 0.12% 85
2023
Q4 		$22.9M Sell
6,493,785
-299,941
-4% -$861K 0.14% 74
2023
Q3 		$17.6M Sell
6,793,726
-168,511
-2% -$592K 0.13% 82
2023
Q2 		$27.4M Buy
6,962,237
+137,713
+2% +$437K 0.18% 68
2023
Q1 		$23.1M Sell
6,824,524
-196,468
-3% -$801K 0.16% 66
2022
Q4 		$25.1M Sell
7,020,992
-318,535
-4% -$1.36M 0.22% 59
2022
Q3 		$29.6M Sell
7,339,527
-514,945
-7% -$2.64M 0.21% 67
2022
Q2 		$54.1M Sell
7,854,472
-521,958
-6% -$3.77M 0.32% 51
2022
Q1 		$71.1M Buy
8,376,430
+434,873
+5% +$3.06M 0.3% 53
2021
Q4 		$70.1M Buy
7,941,557
+2,043,985
+35% +$19.4M 0.21% 69
2021
Q3 		$61.3M Buy
5,897,572
+1,964,340
+50% +$17.2M 0.15% 97
2021
Q2 		$41.3M Buy
+3,933,232
New +$38.8M 0.08% 138

Other funds holding SRTA

TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

ARK Investment Management's SRTA Position: Q1 2026 in Review

ARK Investment Management increased its Strata Critical Medical Inc (SRTA) stake by 4.8% in Q1 2026, buying an estimated $1.66M and bringing the position to 7,455,284 shares worth $31.2M. The position accounts for 0.24% of the portfolio, ranked #65.

ARK Investment Management first reported a position in SRTA in Q2 2021 and has held it in 20 quarters since. The position peaked at $71.1M in Q1 2022. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • ARK Investment Management held 7,455,284 shares of Strata Critical Medical Inc worth $31.2M as of Q1 2026.
  • ARK Investment Management bought 344,624 Strata Critical Medical Inc shares in Q1 2026, an estimated $1.66M.
  • Strata Critical Medical Inc made up 0.24% of ARK Investment Management's portfolio in Q1 2026, its #65 holding.
  • ARK Investment Management first reported a position in Strata Critical Medical Inc in Q2 2021 and has held it in 20 quarters since.
  • ARK Investment Management's Strata Critical Medical Inc position peaked at $71.1M in Q1 2022.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on ARK Investment Management's 13F filing for Q1 2026, filed 12 May 2026.